Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biol Chem ; 271(51): 32487-90, 1996 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-8955067

RESUMO

CrmA, a poxvirus gene product with a serpin-like structure, blocks a variety of apoptotic death events in cultured cells. Based on the ability of CrmA to inhibit the interleukin-1beta converting enzyme in vitro, it has been speculated that interleukin-1beta converting enzyme-related proteases (caspases) essential for apoptosis are the cellular targets of CrmA. Here we found that rabbitpox virus CrmA/SPI-2 inhibits the cleavage of lamin A mediated by a caspase in our cell-free system of apoptosis. In the presence of CrmA/SPI-2, nuclear apoptosis in vitro was blocked at an intermediate stage after collapse of the chromatin against the nuclear periphery and before nuclear shrinkage and disintegration into apoptotic body-like fragments. Using N-(acetyltyrosinylvalinyl-Nepsilon-biotinyllysyl) aspartic acid [(2,6-dimethylbenzoyl)oxy] methyl ketone, which derivatizes the active forms of caspases, we could show that one of five caspases active in the extracts is inhibited both by CrmA/SPI-2 and by a peptide spanning the lamin A apoptotic cleavage site. These results reveal that CrmA/SPI-2 can inhibit a caspase responsible both for lamin A cleavage and for the nuclear disintegration characteristic of apoptosis.


Assuntos
Cisteína Endopeptidases/metabolismo , Fragmentação do DNA/efeitos dos fármacos , Endopeptidases/metabolismo , Inibidores Enzimáticos/farmacologia , Proteínas Nucleares/metabolismo , Serpinas/farmacologia , Animais , Apoptose , Caspase 1 , Sistema Livre de Células , Galinhas , Inibidores de Cisteína Proteinase/farmacologia , Lamina Tipo A , Laminas , Poli(ADP-Ribose) Polimerases/metabolismo , Poxviridae/enzimologia , Proteínas Virais/farmacologia
2.
Proc Natl Acad Sci U S A ; 93(17): 9108-13, 1996 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-8799162

RESUMO

Cytotoxic T lymphocytes are important effectors of antiviral immunity, and they induce target cell death either by secretion of cytoplasmic granules containing perforin and granzymes or by signaling through the Fas cell surface antigen. Although it is not known whether the granule-mediated and Fas-mediated cytolytic mechanisms share common components, proteinase activity has been implicated as an important feature of both pathways. The orthopoxviruses cowpox virus and rabbitpox virus each encode three members of the serpin family of proteinase inhibitors, designated SPI-1, SPI-2, and SPI-3. Of these, SPI-2 (also referred to as cytokine response modifier A in cowpox virus) has been shown to inhibit the proteolytic activity of both members of the interleukin 1 beta converting enzyme family and granzyme B. We report here that cells infected with cowpox or rabbitpox viruses exhibit resistance to cytolysis by either cytolytic mechanism. Whereas mutation of the cytokine response modifier A/SPI-2 gene was necessary to relieve inhibition of Fasmediated cytolysis, in some cell types mutation of SPI-1, in addition to cytokine response modifier A/SPI-2, was necessary to completely abrogate inhibition. In contrast, viral inhibition of granule-mediated killing was unaffected by mutation of cytokine response modifier A/SPI-2 alone, and it was relieved only when both the cytokine response modifier A/SPI-2 and SPI-1 genes were inactivated. These results suggest that an interleukin 1 beta converting enzyme-like enzymatic activity is involved in both killing mechanisms and indicate that two viral proteins, SPI-1 and cytokine response modifier A/SPI-2, are necessary to inhibit both cytolysis pathways.


Assuntos
Grânulos Citoplasmáticos/metabolismo , Citotoxicidade Imunológica , Orthopoxvirus/metabolismo , Inibidores de Serina Proteinase/metabolismo , Proteínas Virais/metabolismo , Receptor fas/metabolismo , Animais , Linhagem Celular , Peptídeos e Proteínas de Sinalização Intercelular , Camundongos , Mutação , Peptídeos/genética , Peptídeos/metabolismo , Inibidores de Serina Proteinase/genética , Serpinas/genética , Serpinas/metabolismo , Proteínas Virais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...